About
Director's Message
About Us
Our Management and Teams
Contact Us
Innovation
Organ and Tissue Regeneration
Cell Therapy
Drug Discovery
Translation
Partners
News
Highlights of CRMH
Scientific progress
Up-Coming Events
Tenders
Join Us
Why CRMH
Current Vacancies
English
Eng
繁
News
Home
/
News
/
News
DEC 19, 2023
The Greate Bay Area Stem Cell International Symposium and the 13th Guangzhou International Stem Cell and Regenerative Medicine Symposium Hong Kong Division was successfully held in Hong Kong
Learn More
DEC 19, 2023
The 13th Guangzhou International Stem Cell and Regenerative Medicine Symposium Successfully Held
Learn More
DEC 12, 2023
A delegation led by Lu Fangjun, Deputy Director of the Bureau of science communication, Chinese Academy of sciences, Wang Yifang, Academician of Chinese Academy of Sciences and Director of the Institute of High Energy Physics, Chinese Academy of Sciences, and Zhao Zhentang, Academician of the Chinese Academy of Engineering and Director of the Shanghai Synchrotron Radiation Facility, visited the research center for investigation and research.
Learn More
DEC 06, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine Third Round Announcement
Learn More
DEC 01, 2023
The 4th Annual Meeting of the Max Planck-GIBH Joint Center for Regenerative Biomedicine and the CUHK-MPI-GIBH-CRMH Joint Forum on Stem Cells and Molecular Medicine were successfully held at The Chinese University of Hong Kong (CUHK) Faculty of Biomedical Sciences
Learn More
NOV 29, 2023
中國科學院重大科技基礎設施香港交流分享活動
Learn More
SEP 27, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine Second Round Announcement
Learn More
SEP 18, 2023
Wang Keqiang Visits Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences and Shenzhen Institute of Advanced Technology
Learn More
JUN 24, 2024
New Progress in the Development of Genetically Engineered Macrophages from Human Pluripotent Stem Cells for Cancer Therapy
Learn More
JUN 24, 2024
A First-of-its-Kind Discovery published on Mol Cancer by the Pei Duanqing Team at Westlake University
Learn More
JUL 01, 2022
习近平考察香港科学园
Learn More
MAY 15, 2022
Self-Developed and Marketed Class 1 Novel Drug Orelabrutinib Selected as One of China's 2021 Major Medical Advancements, Included in the 2022 Edition of the CSCO Malignant Hematology Treatment Guidelines
Learn More
<
1
…
3
>
About
Director's Message
About Us
Our Management and Teams
Contact Us
Innovation
Organ and Tissue Regeneration
Cell Therapy
Drug Discovery
Translation
Partners
News
Highlights of CRMH
Scientific progress
Up-Coming Events
Tenders
Join Us
Why CRMH
Current Vacancies